The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate

NCT00427219 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hypertrophy

Interventions

DRUG: Ozarelix
DRUG: Placebo

Sponsor

Spectrum Pharmaceuticals, Inc